Aberrant high expression of immunoglobulin G in epithelial stem/progenitor-like cells contributes to tumor initiation and metastasis

Citations Over TimeTop 18% of 2015 papers

Abstract

High expression of immunoglobulin G (IgG) in many non-B cell malignancies and its non-conventional roles in promoting proliferation and survival of cancer cells have been demonstrated. However, the precise function of non-B IgG remains incompletely understood. Here we define the antigen specificity of RP215, a monoclonal antibody that specifically recognizes the IgG in cancer cells. Using RP215, our study shows that IgG is overexpressed in cancer cells of epithelial lineage, especially cells with cancer stem/progenitor cell-like features. The RP215-recognized IgG is primarily localized on the cell surface, particularly lamellipodia-like structures. Cells with high IgG display higher migration, increased invasiveness and metastasis, and enhanced self-renewal and tumorgenecity ability in vitro and in vivo. Importantly, depletion of IgG in breast cancer leads to reduced adhesion, invasion and self-renewal and increased apoptosis of cancer cells. We conclude that high expression of IgG is a novel biomarker of tumor progression, metastasis and cancer stem cell maintenance and demonstrate the potential therapeutic benefits of RP215-recognized IgG targeted strategy.

Related Papers

• → Molecular cloning of a novel immunoglobulin superfamily gene preferentially expressed by brain and testis(2002)74 cited
• → Neural immunoglobulin superfamily interaction networks(2017)71 cited
• → Regulatory interactions between members of the immunoglobulin superfamily(1988)42 cited
• → Molecular Evolution and the Immunoglobulin Gene Superfamily(1991)5 cited
• → Immunoglobulin Superfamily and the Nervous System(2004)1 cited